ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $467,000 | +7.4% | 8,326 | +24.9% | 0.02% | +13.3% |
| Q4 2021 | $435,000 | -58.7% | 6,666 | -52.5% | 0.02% | -55.9% |
| Q3 2021 | $1,052,000 | +3087.9% | 14,025 | +3184.5% | 0.03% | +3300.0% |
| Q2 2021 | $33,000 | -98.1% | 427 | -98.0% | 0.00% | -98.3% |
| Q1 2021 | $1,717,000 | +402.0% | 20,966 | +407.2% | 0.06% | +286.7% |
| Q4 2020 | $342,000 | -27.5% | 4,134 | -43.1% | 0.02% | -70.0% |
| Q3 2020 | $472,000 | -57.6% | 7,260 | -59.6% | 0.05% | -59.7% |
| Q2 2020 | $1,112,000 | +16.1% | 17,956 | +29.8% | 0.12% | -45.1% |
| Q4 2019 | $958,000 | +569.9% | 13,830 | +510.6% | 0.23% | +451.2% |
| Q3 2019 | $143,000 | -4.0% | 2,265 | -11.4% | 0.04% | -30.5% |
| Q1 2019 | $149,000 | +40.6% | 2,555 | +48.9% | 0.06% | +18.0% |
| Q4 2018 | $106,000 | -80.1% | 1,716 | -74.8% | 0.05% | -72.5% |
| Q3 2018 | $532,000 | +274.6% | 6,821 | +174.5% | 0.18% | +149.3% |
| Q1 2018 | $142,000 | – | 2,485 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |